SG Americas Securities’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-38,541
| Closed | -$143K | – | 3033 |
|
|
2017
Q4 | $143K | Buy |
38,541
+25,464
| +195% | +$94.5K | ﹤0.01% | 2233 |
|
|
2017
Q3 | $53K | Buy |
+13,077
| New | +$53K | ﹤0.01% | 2848 |
|
|
2017
Q2 | – | Sell |
-11,456
| Closed | -$47K | – | 3147 |
|
|
2017
Q1 | $47K | Buy |
+11,456
| New | +$47K | ﹤0.01% | 2733 |
|
|
2015
Q4 | – | Sell |
-5,842
| Closed | -$96K | – | 2626 |
|
|
2015
Q3 | $96K | Buy |
5,842
+3,797
| +186% | +$62.4K | ﹤0.01% | 1893 |
|
|
2015
Q2 | $46K | Sell |
2,045
-7,148
| -78% | -$161K | ﹤0.01% | 2059 |
|
|
2015
Q1 | $90K | Sell |
9,193
-3,623
| -28% | -$35.5K | ﹤0.01% | 1992 |
|
|
2014
Q4 | $146K | Buy |
12,816
+8,616
| +205% | +$98.2K | ﹤0.01% | 2384 |
|
|
2014
Q3 | $48K | Sell |
4,200
-12,053
| -74% | -$138K | ﹤0.01% | 2114 |
|
|
2014
Q2 | $316K | Buy |
+16,253
| New | +$316K | ﹤0.01% | 1640 |
|
|
2013
Q3 | – | Sell |
-9,389
| Closed | -$88K | – | 2585 |
|
|
2013
Q2 | $88K | Buy |
+9,389
| New | +$88K | ﹤0.01% | 1770 |
|